Biểu đồ giá cổ phiếu FBRX
FBRX Thu nhập
Forte Biosciences Inc
$26.38
-1.54%
$-0.41
Khi đóng cửa: Apr 28, 16:00:00 GMT-4
$27.23
3.2%
$0.84
Phiên trước giờ: Apr 29, 07:19:16 GMT-4
Quay lại
Forte Biosciences Inc (FBRX) Thu nhập
Thống kê chính
Giá đóng cửa trước
$26.8
Giá mở cửa
$26.75
Phạm vi ngày
$26.1 - $27.23
Phạm vi 52 tuần
$4.9 - $35.79
Khối lượng
229.5K
Khối lượng trung bình
262.3K
Tỷ suất cổ tức
--
EPS (TTM)
-4.71
Vốn hóa thị trường
$508.1M
FBRX là gì?
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The company is headquartered in Dallas, Texas and currently employs 16 full-time employees. The company went IPO on 2017-04-13. The company is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The firm's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.
